Gene Changes Linked To Fever-Triggered Epilepsy In Children

What was studied

This study looked at 61 children treated at one children's hospital in China who had epilepsy related to fever sensitivity and met the study's inclusion criteria. All of them had whole exome sequencing, a broad genetic test. The researchers compared 30 children who had abnormal genetic testing related to febrile sensitivity epilepsy with 31 children whose testing did not identify such findings.

They also looked more closely at the 30 gene-positive children to summarize which genes were involved, what epilepsy syndromes they had, and whether treatment was judged "effective" or "ineffective" in their records. This was a retrospective study, meaning the researchers reviewed past medical and genetic data rather than following children forward in time.

What they found

Among the 30 children with a gene finding, seizures often started very early: 20 started within the first year of life, and 17 had developmental delay. The most common genes were SCN1A (13 children), PCDH19 (4), ADGRV1 (3), and CACNB4 (2). Single cases were found in several other genes, including SCN2A, PRRT2, CACNA1A, CACNA1E, CACNA1H, KCNA2, CHD2, and KIAA2022. The authors reported KIAA2022 as a novel epilepsy-related mutation in this cohort.

The most common diagnoses in the gene-positive group were Dravet syndrome (11 children), PCDH19-related epilepsy (4), and generalized epilepsy with febrile seizures plus (4). Compared with children who were gene-negative, the gene-positive children had earlier seizure onset, more status epilepticus, and more developmental delay after seizures began.

Within the gene-positive group, treatment response differed by ACMG pathogenicity level, mutation type or gene, and whether seizures started at age 1 year or younger. The study did not find treatment-response differences by sex, by whether status epilepticus occurred, or by whether the gene was an ion channel gene.

Limits of the evidence

This was a small study from a single hospital, so the results may not apply to all children with fever-sensitive epilepsy. It was retrospective, so it can show associations and patterns but cannot establish causation or determine whether a genetic finding led to a better or worse treatment response.

The abstract gives limited detail about how "effective" treatment was defined, which medicines were used, and how long children were followed. Some genes were found in only 1 child, so those findings are uncertain. The report also describes KIAA2022 as a novel epilepsy-related mutation, but the abstract alone does not provide enough detail to confirm a broader gene-disease relationship.

For families and caregivers

For families, this study suggests that in children whose seizures are linked to fever sensitivity, certain features were more common in those with positive genetic findings: seizures starting very early, especially in the first year of life, status epilepticus, and developmental delay. In this group, SCN1A and PCDH19 were common findings, and Dravet syndrome was a common diagnosis.

These results are in line with the authors' view that early genetic testing may be helpful in infants and young children with these features. But this study does not show which treatment is best for each gene, and care still needs to be individualized.

What to watch next

Larger, multi-center studies with clearer definitions of treatment response and longer follow-up could help clarify how specific gene findings relate to outcomes.

Terms in this summary

whole exome sequencing

A genetic test that looks at the protein-coding parts of many genes at once.

status epilepticus

A seizure that lasts a long time or repeated seizures without full recovery in between; this is a medical emergency.

developmental delay

When a child is slower than expected in skills such as speech, movement, learning, or social development.

Dravet syndrome

An epilepsy syndrome that often begins in infancy and is commonly linked to SCN1A gene changes.

PCDH19-related epilepsy

A genetic epilepsy linked to changes in the PCDH19 gene, often with fever-related seizures.

ACMG classification

A standard system used by genetics experts to rate how likely a gene change is to be disease-causing.

genotype

A person's genetic makeup or specific gene changes.

phenotype

The observable features of a condition, such as seizure type, age at onset, and development.